消息
loading
Lisdexamfetamine for the management of ADHD in adults

Publisher: John Wiley & Sons Inc

E-ISSN: 1931-2253|26|21|12-14

ISSN: 0959-6682

Source: PRESCRIBER, Vol.26, Iss.21, 2015-11, pp. : 12-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Lisdexamfetamine is now licensed for use in adults with attention deficit hyperactivity disorder (ADHD) under the brand name Elvanse Adult. This article summarises its indications and adverse effects and discusses clinical trial evidence for its efficacy in adults.

Related content